Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05487235
Title A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications

head and neck squamous cell carcinoma

lung non-small cell carcinoma

melanoma

Advanced Solid Tumor

Therapies

Atezolizumab + RLY-1971

Atezolizumab + Omeprazole + RLY-1971

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
Fundacion CORI para la Investigacion y Prevencion del Cancer Recruiting La Rioja F5300COE Argentina Details
Border Medical Oncology Recruiting Wodonga New South Wales 3690 Australia Details
One Clinical Research Perth Recruiting Nedlands Western Australia 6009 Australia Details
Ottawa Hospital Recruiting Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Centre Recruiting Toronto Ontario M5G 1Z5 Canada Details
Chungbuk National University Hospital Recruiting Cheongju-si 28644 Korea, Republic of Details
Seoul National University Hospital Recruiting Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Recruiting Seoul 03722 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field